GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » Revenue

Xiangxue Pharmaceutical Co (SZSE:300147) Revenue : ¥2,279 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co Revenue?

Xiangxue Pharmaceutical Co's revenue for the three months ended in Mar. 2024 was ¥569 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,279 Mil. Xiangxue Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.80. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.17.

Warning Sign:

Xiangxue Pharmaceutical Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Xiangxue Pharmaceutical Co was -14.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -9.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -4.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Xiangxue Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 34.70% per year. The lowest was -9.30% per year. And the median was 11.95% per year.


Xiangxue Pharmaceutical Co Revenue Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co Revenue Chart

Xiangxue Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,786.20 3,072.09 2,970.58 2,187.07 2,299.29

Xiangxue Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 588.73 612.63 526.83 571.11 568.86

Competitive Comparison of Xiangxue Pharmaceutical Co's Revenue

For the Biotechnology subindustry, Xiangxue Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xiangxue Pharmaceutical Co's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiangxue Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Xiangxue Pharmaceutical Co's Revenue falls into.



Xiangxue Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,279 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xiangxue Pharmaceutical Co  (SZSE:300147) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Xiangxue Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiangxue Pharmaceutical Co (SZSE:300147) Business Description

Traded in Other Exchanges
N/A
Address
No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663
Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.
Executives
Huang Wei Hua Supervisors
Tan Wen Hui Director
Kang Zhi Ying Executives
Ceng Lun Executives
Liu Yan Executives
Lu Feng Executives
Xu Li Secretary, Director
Mo Zi Yu Supervisors
Mai Zhen Jiang Supervisors
Wang Yong Hui Directors, executives
He Tao Executives
Fang Wei Min Supervisors
Huang Bin Directors, Directors, and Executives
Wu Jun Executives
Chen Wen Jin Executives

Xiangxue Pharmaceutical Co (SZSE:300147) Headlines

No Headlines